Home Chronic Kidney Disease Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation

Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation

Credits to the Source Link Obum
Peri- and Post-operative Evaluation and Management of Atypical Hemolytic Uremic Syndrome (aHUS) in Kidney Transplantation
    • Goodship T.H.
    • Cook H.T.
    • Fakhouri F.
    • et al.

    Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “kidney disease: improving Global outcomes” (KDIGO) Controversies conference.

    Kidney Int. 2017; 91: 539-551

    • Grenda R.
    • Jarmuzek W.
    • Rubik J.
    • et al.

    Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.

    Pediatr Transpl. 2015; 19: E130-E134

    • Java A.
    • Atkinson J.
    • Salmon J.

    Defective complement inhibitory function predisposes to renal disease.

    Annu Rev Med. 2013; 64: 307-324

    • Liszewski M.K.
    • Java A.
    • Schramm E.C.
    • Atkinson J.P.

    Complement dysregulation and disease: insights from contemporary genetics.

    Annu Rev Pathol. 2017; 12: 25-52

    • Rodriguez de Cordoba S.
    • Hidalgo M.S.
    • Pinto S.
    • Tortajada A.

    Genetics of atypical hemolytic uremic syndrome (aHUS).

    Semin Thromb Hemost. 2014; 40: 422-430

    • Dragon-Durey M.A.
    • Sethi S.K.
    • Bagga A.
    • et al.

    Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome.

    J Am Soc Nephrol. 2010; 21: 2180-2187

    • Le Quintrec M.
    • Zuber J.
    • Moulin B.
    • et al.

    Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.

    Am J Transplant. 2013; 13: 663-675

    • Noris M.
    • Caprioli J.
    • Bresin E.
    • et al.

    Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.

    Clin J Am Soc Nephrol. 2010; 5: 1844-1859

    • Bresin E.
    • Daina E.
    • Noris M.
    • et al.

    Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.

    Clin J Am Soc Nephrol. 2006; 1: 88-99

    • Salvadori M.
    • Bertoni E.

    Update on hemolytic uremic syndrome: diagnostic and therapeutic recommendations.

    World J Nephrol. 2013; 2: 56-76

    • Lemaire M.
    • Fremeaux-Bacchi V.
    • Schaefer F.
    • et al.

    Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome.

    Nat Genet. 2013; 45: 531-536

    • Noris M.
    • Remuzzi G.

    Atypical hemolytic-uremic syndrome.

    N Engl J Med. 2009; 361: 1676-1687

    • Legendre C.M.
    • Licht C.
    • Muus P.
    • et al.

    Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.

    N Engl J Med. 2013; 368: 2169-2181

    • Noris M.
    • Remuzzi G.

    Managing and preventing atypical hemolytic uremic syndrome recurrence after kidney transplantation.

    Curr Opin Nephrol Hypertens. 2013; 22: 704-712

    • Fakhouri F.
    • Roumenina L.
    • Provot F.
    • et al.

    Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations.

    J Am Soc Nephrol. 2010; 21: 859-867

    • Kavanagh D.
    • Richards A.
    • Fremeaux-Bacchi V.
    • et al.

    Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.

    Clin J Am Soc Nephrol. 2007; 2: 591-596

    • Richards S.
    • Aziz N.
    • Bale S.
    • et al.

    Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

    Genet Med. 2015; 17: 405-424

    • Kavanagh D.
    • Anderson H.E.

    Interpretation of genetic variants of uncertain significance in atypical hemolytic uremic syndrome.

    Kidney Int. 2012; 81: 11-13

    • Java A.
    • Pozzi N.
    • Love-Gregory L.D.
    • et al.

    A multimodality approach to assessing factor I genetic variants in atypical hemolytic uremic syndrome.

    Kidney Int Rep. 2019; 4: 1007-1017

    • Cecka J.M.

    The UNOS scientific renal transplant Registry.

    Clin Transpl. 1999; : 1-21

    • Casiraghi F.
    • Azzollini N.
    • Todeschini M.
    • et al.

    Complement alternative pathway deficiency in recipients protects kidney allograft from ischemia/reperfusion injury and alloreactive T cell response.

    Am J Transpl. 2017; 17: 2312-2325

    • Yu Z.X.
    • Qi S.
    • Lasaro M.A.
    • et al.

    Targeting complement pathways during cold ischemia and reperfusion prevents delayed graft function.

    Am J Transpl. 2016; 16: 2589-2597

    • Wong E.
    • Challis R.
    • Sheerin N.
    • et al.

    Patient stratification and therapy in atypical haemolytic uraemic syndrome (aHUS).

    Immunobiology. 2016; 221: 715-718

    • McNamara L.A.
    • Topaz N.
    • Wang X.
    • et al.

    High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine.

    MMWR Morb Mortal Wkly Rep. 2017; 66: 734-737

    • Duineveld C.
    • Verhave J.C.
    • Berger S.P.
    • van de Kar N.
    • Wetzels J.F.M.

    Living donor kidney transplantation in atypical hemolytic uremic syndrome: a case series.

    Am J Kidney Dis. 2017; 70: 770-777

    • Waters A.M.
    • Pappworth I.
    • Marchbank K.
    • et al.

    Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T.

    Am J Transpl. 2010; 10: 168-172

    • Zuber J.
    • Fakhouri F.
    • Roumenina L.T.
    • Loirat C.
    • Fremeaux-Bacchi V.

    Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.

    Nat Rev Nephrol. 2012; 8: 643-657

    • Matar D.
    • Naqvi F.
    • Racusen L.C.
    • et al.

    Atypical hemolytic uremic syndrome recurrence after kidney transplantation.

    Transplantation. 2014; 98: 1205-1212

    • Kumar A.
    • Stewart Z.
    • Reed A.
    • et al.

    Successful prophylactic use of eculizumab in aHUS kidney transplant patients: a report of 9 cases.

    Am J Transpl. 2016; 16

    • Levi C.
    • Fremeaux-Bacchi V.
    • Zuber J.
    • et al.

    Midterm outcomes of 12 renal transplant recipients treated with eculizumab to prevent atypical hemolytic syndrome recurrence.

    Transplantation. 2017; 101: 2924-2930

    • Siedlecki A.M.
    • Isbel N.
    • Vande Walle J.
    • et al.

    Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome.

    Kidney Int Rep. 2019; 4: 434-446

    • Dragon-Durey M.-A.
    • Loirat C.
    • Cloarec S.
    • et al.

    Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome.

    J Am Soc Nephrol. 2005; 16: 555-563

    • Remuzzi G.
    • Ruggenenti P.
    • Codazzi D.
    • et al.

    Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.

    Lancet. 2002; 359: 1671-1672

    • Zuber J.
    • Le Quintrec M.
    • Sberro-Soussan R.
    • et al.

    New insights into postrenal transplant hemolytic uremic syndrome.

    Nat Rev Nephrol. 2011; 7: 23-35

    • Fremeaux-Bacchi V.
    • Arzouk N.
    • Ferlicot S.
    • et al.

    Recurrence of HUS due to CD46/MCP mutation after renal transplantation: a role for endothelial microchimerism.

    Am J Transpl. 2007; 7: 2047-2051

    • Zuber J.
    • Le Quintrec M.
    • Morris H.
    • et al.

    Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation.

    Transpl Rev (Orlando). 2013; 27: 117-125

    • Alasfar S.
    • Alachkar N.

    Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature.

    Front Med (Lausanne). 2014; 1: 52https://doi.org/10.3389/fmed.2014.00052

    • Stevenson S.
    • Mallett A.
    • Oliver K.
    • et al.

    Atypical HUS associated with severe, unexpected antibody-mediated rejection post kidney transplant.

    Nephrology (Carlton). 2014; 19: 22-26

    • Meehan S.M.
    • Kremer J.
    • Ali F.N.
    • et al.

    Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.

    Clin J Am Soc Nephrol. 2011; 6: 395-403

    • Java A.
    • Edwards A.
    • Rossi A.
    • et al.

    Cytomegalovirus-induced thrombotic microangiopathy after renal transplant successfully treated with eculizumab: case report and review of the literature.

    Transpl Int. 2015; 28: 1121-1125

    • Lopes da Silva R.

    Viral-associated thrombotic microangiopathies.

    Hematol Oncol Stem Cell Ther. 2011; 4: 51-59

    • Renner B.
    • Klawitter J.
    • Goldberg R.
    • et al.

    Cyclosporine induces endothelial cell release of complement-activating microparticles.

    J Am Soc Nephrol. 2013; 24: 1849-1862

  • Soliris (eculizumab). Highlights of Prescribing Information. https://alexion.com/Documents/Soliris_USPI.pdf. Updated June 2019. Accessed May 22, 2020.

    • Dedhia P.
    • Govil A.
    • Mogilishetty G.
    • et al.

    Eculizumab and belatacept for de novo atypical hemolytic uremic syndrome associated with CFHR3-CFHR1 deletion in a kidney transplant recipient: a case report.

    Transpl Proc. 2017; 49: 188-192

    • Garg N.
    • Rennke H.G.
    • Pavlakis M.
    • Zandi-Nejad K.

    De novo thrombotic microangiopathy after kidney transplantation.

    Transpl Rev (Orlando). 2018; 32: 58-68

    • Le Quintrec M.
    • Lionet A.
    • Kamar N.
    • et al.

    Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation.

    Am J Transpl. 2008; 8: 1694-1701

    • Brown J.H.
    • Tellez J.
    • Wilson V.
    • et al.

    Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation.

    Am J Transpl. 2012; 12: 1632-1636

  • Source Link

    Related Posts

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More